Assignee
KYMERA THERAPEUTICS INC
US43 patents
Top patents by PatentIndex Score
US10874743B2Dec 29, 2020
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC38 citations98
US11352350B2Jun 7, 2022
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC20 citations94
US11292792B2Apr 5, 2022
Tricyclic CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC19 citations94
US11117889B1Sep 14, 2021
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC28 citations94
US12258341B2Mar 25, 2025
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations86
US12168057B2Dec 17, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations86
US11807636B2Nov 7, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC6 citations86
US11746120B2Sep 5, 2023
Stat degraders and uses thereof
KYMERA THERAPEUTICS INC12 citations86
US11723980B2Aug 15, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC9 citations86
US11512080B2Nov 29, 2022
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC15 citations86
US11485750B1Nov 1, 2022
STAT degraders and uses thereof
KYMERA THERAPEUTICS INC7 citations86
US11485743B2Nov 1, 2022
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC6 citations86
US11358948B2Jun 14, 2022
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC16 citations86
US11779578B2Oct 10, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC7 citations85
US11707457B2Jul 25, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC11 citations85
US11591332B2Feb 28, 2023
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC9 citations85
US11318205B1May 3, 2022
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC10 citations83
US12187744B2Jan 7, 2025
IRAK4 degraders and synthesis thereof
KYMERA THERAPEUTICS INC6 citations78
US11685750B2Jun 27, 2023
Crystalline forms of IRAK degraders
KYMERA THERAPEUTICS INC13 citations78
US12077555B2Sep 3, 2024
STAT degraders and uses thereof
KYMERA THERAPEUTICS INC3 citations75
US12006329B2Jun 11, 2024
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC4 citations75
US11773103B2Oct 3, 2023
IRAK4 degraders and uses thereof
KYMERA THERAPEUTICS INC11 citations75
US12150995B2Nov 26, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC4 citations74
US11857535B2Jan 2, 2024
Methods of treating mutant lymphomas
KYMERA THERAPEUTICS INC6 citations74
US11932624B2Mar 19, 2024
MDM2 degraders and uses thereof
KYMERA THERAPEUTICS INC2 citations73
US11623932B2Apr 11, 2023
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC3 citations73
US12091411B2Sep 17, 2024
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC5 citations71
US11679109B2Jun 20, 2023
SMARCA degraders and uses thereof
KYMERA THERAPEUTICS INC3 citations71
US12171768B2Dec 24, 2024
IRAK4 degraders and uses thereof
KYMERA THERAPEUTICS INC6 citations70
US12516068B2Jan 6, 2026
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC1 citations64
US12454520B2Oct 28, 2025
Protein degraders and uses thereof
KYMERA THERAPEUTICS INC1 citations64
US12539295B2Feb 3, 2026
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations62
US12540127B2Feb 3, 2026
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC0 citations62
US12528785B2Jan 20, 2026
MDM2 degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations62
US11932635B2Mar 19, 2024
CRBN ligands and uses thereof
KYMERA THERAPEUTICS INC1 citations62
US11897882B2Feb 13, 2024
Tricyclic crbn ligands and uses thereof
KYMERA THERAPEUTICS INC1 citations62
US12097261B2Sep 24, 2024
CDK2 degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations58
US12558427B2Feb 24, 2026
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations52
US12551564B2Feb 17, 2026
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations52
US12545659B2Feb 10, 2026
IRAK degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations51
US12569485B2Mar 10, 2026
SMARCA inhibitors and uses thereof
KYMERA THERAPEUTICS INC0 citations50
US12521438B2Jan 13, 2026
SMARCA degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations50
US12497402B2Dec 16, 2025
IRAK4 degraders and uses thereof
KYMERA THERAPEUTICS INC0 citations49